Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study

Effects on the diagnosis change and on the disability level for individuals with disorder of consciousness

(2018) Davide Sattin et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials

(2017) Natan M. Bornstein et al.   NEUROLOGICAL SCIENCES

Early consciousness disorder in acute ischemic stroke: incidence, risk factors and outcome

(2016) Jie Li et al.   BMC Neurology

Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis

(2013) Sonia Ruiz de Azua et al.   BMC Psychiatry

Disorders Of Consciousness And Pharmaceuticals That Act On Oxygen Based Amino Acid And Monoamine Neurotransmitter Pathways Of The Brain

(2013) Ralf Clauss   CURRENT PHARMACEUTICAL DESIGN

Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010

(2013) Valery L Feigin et al.   LANCET

Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury

(2012) Joseph T. Giacino et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cerebrolysin in Patients With Acute Ischemic Stroke in Asia

(2012) Wolf-Dieter Heiss et al.   STROKE

Neurological complications of acute ischaemic stroke

(2011) Joyce S Balami et al.   LANCET NEUROLOGY

Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke

(2010) Chunling Zhang et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Neurotransmitters in Coma, Vegetative and Minimally Conscious States, pharmacological interventions

(2010) R.P. Clauss   MEDICAL HYPOTHESES

The cost of cerebral ischaemia

(2008) R.W.V. Flynn et al.   NEUROPHARMACOLOGY